For human
prostate cancer, the chromosome 8p21 locus, which contains NKX3.1 and the
microRNA (miR)-3622 family (miR-3622a/b), is a frequently deleted region. Thus, miR-3622 is proposed as a suppressor for
prostate cancer, but its role remains debatable. In the present study, we found that expression of miR-3622a was lower, whereas expression of miR-3622b-3p was higher in human
prostate cancer tissues than in normal prostate tissues. miR-3622a-3p inhibited cell migration and invasion of human
prostate cancer cells, whereas miR-3622b-3p facilitated cell proliferation, migration, and invasion. To address the opposing roles of miR-3622 family members in various human
prostate cancer cell lines, we knocked out (KO) endogenous miR-3622, including both miR-3622a/b. Our results showed that miR-3622 KO reduced cell proliferation, migration, and invasion in vitro and
tumor growth and
metastasis in vivo. Functional analyses revealed that miR-3622 regulated the p53-downstream gene network, including AIFM2, c-MYC, and p21, to control apoptosis and the cell cycle. Furthermore, using CRISPR interference,
miRNA/
mRNA immunoprecipitation assays, and dual-
luciferase assays, we established that AIFM2, a direct target of miR-3622b-3p, is responsible for miR-3622 KO-induced apoptosis. We identified an miR-3622-AIFM2 axis that contributes to oncogenic function during
tumor progression. In addition, miR-3622 KO inhibited the epithelial-mesenchymal transition involved in
prostate cancer metastasis via upregulation of
vimentin. The results show that miR-3622b-3p is upregulated in human
prostate cancers and has an oncogenic function in
tumor progression and
metastasis via repression of p53 signaling, especially through an miR-3622-AIFM2 axis. In contrast, for human
prostate cancer, deletion of the miR-3622 locus at 8p21 reduced the oncogenic effects on
tumor progression and
metastasis.